Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant factors » significant predictors (Expand Search)
significant facies » significant species (Expand Search), significant factor (Expand Search), significant barriers (Expand Search)
Showing 2,421 - 2,440 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant facies) OR (significant factors)) decrease ))', query time: 0.40s Refine Results
  1. 2421
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2422
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2423
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  4. 2424
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 2425
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2426
    The ANCOVA and Post_hoc results.

    The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 2427
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 2428
    CONSORT flowchart.

    CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 2429
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2430
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2431
    Time to stabilization in the mediolateral direction.

    Time to stabilization in the mediolateral direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 2432
    Outpatient utilization of anticoagulants from 2019 to 2023.

    Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2433
    Participant’s data including characteristics and primary outcome measurement.

    Participant’s data including characteristics and primary outcome measurement. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 2434
    Time to stabilization in the vertical direction.

    Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 2435
    DDC for four anticoagulants from 2019 to 2023.

    DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2436
    Utilization of anticoagulants from 2019 to 2023.

    Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2437
    The description of games.

    The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 2438
    The expenditure on anticoagulants in the period of 2019-2023(million CNY).

    The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2439
    The description of balance training.

    The description of balance training. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2440
    Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels.

    Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels. by Qi He (384033)

    Published 2025
    Save to List
    Saved in:

Search Tools: